Segmental Insights

By Component Analysis

In 2024, the software/platform segment captured a dominant share of the predictive disease analytics market. A growing focus on AI applications, development of tailored solutions, and data interoperability through cloud-based platforms are fostering the segmental growth. Platforms, like IBM Watson, are used in Oncology and Genomics in the analysis of genetic data and scientific literature to facilitate customized cancer treatment recommendations.

Whereas the services segment will expand rapidly in the coming era. Advanced services provide an emphasis on clinical, operational, and financial outcomes in healthcare. Also, they offer healthcare professionals with evidence-backed insights to assist diagnoses, estimate patient deterioration and determine high-risk individuals for early intervention. Numerous insurance companies and government agencies are heavily using predictive analytics to study disease risk, find fraudulent claims, and investigate insurance claims before payment settlement.

By Deployment Mode Analysis

The cloud-based segment held the largest share of the predictive disease analytics market in 2024. The segment is propelled by their scalability, flexibility, and minimal initial capital investment compared to on-premise systems. Whereas, government mandates, especially the 21st Century Cures Act in the U.S., are promoting the adoption of FHIR and open APIs to provide data sharing and allow more comprehensive, cloud-based analytics.

Although the hybrid segment is anticipated to expand fastest. Specifically, hybrid architectures highlight regulatory issues by keeping sensitive data local and appeal to the use of the cloud for analysis, with rapid implementation through cloud-native tools. In 2025, a study presented a hybrid model integrating Artificial Neural Networks (ANN) and Extreme Gradient Boosting (XGBoost) to predict the prospects of leishmaniasis.

By Disease Area Analysis

The oncology segment registered dominance in the market in 2024. A huge burden of cancer cases is supporting the broader adoption of advanced AI/machine learning (ML) models and the integration of multi-modal data (genomic, radiomic, clinical). A vital involvement of companies, such as Exact Sciences, Delfi Diagnostics, and Freenome, is establishing innovative multimodal AI platforms for the analysis of cell-free DNA and other blood-based biomarkers to detect multiple cancers at early stages with increased accuracy.

The neurological disorders segment is predicted to witness the fastest growth. A rise in prevalence of Alzheimer's, Parkinson's, multiple sclerosis, and epilepsy, mainly in the geriatric population, is demanding more sophisticated technologies, like neuroimaging (MRI, CT, PET), electrophysiological devices (EEG), and electronic health records (EHRs). Emerging ML models are supporting the analysis of subtle changes in speech patterns, handwriting characteristics (micrographia), and gait (walking patterns).

By Technology Analysis

In 2024, the artificial intelligence segment held the biggest share of the market. The widespread application of AI has leveraged several developments. Such as the use of NLP to detect dengue in Delhi; the evolution of predictive models for outbreaks, like in Tokyo influenza forecast; and hospitals are increasingly using AI in the analysis of X-rays and CT scans to determine signs of diseases, like pneumonia or cancer.

Moreover, the natural language processing segment is estimated to expand at a rapid CAGR. Recent studies demonstrated that NLP assist in processing clinical notes and finding early signs of concerns, such as sepsis or heart failure. This enables timely interventions and optimized patient outcomes. In the last year, Augmedix unveiled an AI-driven medical documentation software for emergency departments, which employs speech recognition and NLP to simplify data capture.

By Application Analysis

The population health management segment accounted for a dominant share of the predictive disease analytics market in 2024. Nowadays, rising instances of chronic disease are fostering a focus on value-based care is impacting the broader adoption of novel solutions. For this, the globe is elevating multi-model integration, such as electronic health records (EHRs), genomic data, medical imaging

On the other hand, the personalized/precision medicine segment will expand rapidly. AI algorithms are widely used in electronic health records (EHRs), genomic data, and medical imaging to find disease patterns and predict individual risk profiles. For instance, Stanford Hospital explores AI models to persistently track critical signs and lab results in the ICU to anticipate patient deterioration (like respiratory failure or cardiac arrest) hours before it is clinically evident.

Browse More Insights of Towards Healthcare:

The global bioanalytical testing services market

The healthcare analytics market

The global genomics life science analytics market

The global life science analytics market

The global clinical data analytics market

The global population health management market

The global artificial intelligence (AI) in life sciences market

Similarly, the global life science & analytical instruments market

The chromatography accessories and consumables market

The global healthcare predictive analytics market

What are the Recent Developments in the Predictive Disease Analytics Market?

• In September 2025, the National Heart Centre Singapore introduced an innovative AI Technology for the rapid prediction of coronary artery disease in a nationwide initiative.
• In July 2025, South Korea-based Seegene Inc., a global company in molecular diagnostics (MDx) solutions, launched STAgora, a next-generation platform for infectious disease analytics.

Predictive Disease Analytics Market Key Players List

• IBM Watson Health
• SAS Institute
• Oracle Health
• Microsoft Healthcare
• Google Health
• Cerner Corporation
• Health Catalyst
• Optum
• Philips Healthcare
• GE HealthCare
• Siemens Healthineers
• IQVIA
• Prognos Health
• Tempus
• Palantir Technologies
  

Segments Covered in the Report

By Component

• Software/Platform (AI & analytics engines, dashboards, ML pipelines)
• Services (implementation, consulting, model training, AI model customization, maintenance)
• Data & Integration Tools (data ingestion, cleaning, interoperability)
  

By Deployment Mode

• Cloud-based (SaaS, PaaS healthcare analytics)
• On-premises (in-hospital systems)
• Hybrid (multi-cloud integration)
  

By Disease Area

• Cardiovascular Diseases
• Oncology (cancer detection & recurrence risk)
• Diabetes & Metabolic Disorders
• Neurological Disorders (Alzheimer's, Parkinson's)
• Infectious Diseases (COVID-19, influenza, emerging diseases)
• Respiratory Diseases (COPD, asthma)
• Others (renal, autoimmune, rare diseases)
  

By Technology

• Artificial Intelligence (machine learning, deep learning)
• Predictive Modeling & Statistical Analytics
• Natural Language Processing (NLP)
• Cloud Computing & Edge Analytics
• Big Data Analytics & Integration
  

By Application

• Population Health Management
• Personalized/Precision Medicine
• Hospital Readmission Reduction
• Chronic Disease Management
• Early Diagnosis & Preventive Care
• Drug Discovery & Clinical Trial Optimization

By Region

• North America
  • U.S.
  • Canada
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Thailand
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Sweden
  • Denmark
  • Norway
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • UAE
  • Saudi Arabia
  • Kuwait
    

Immediate Delivery Available | Buy This Premium Research @

Access our exclusive, data-rich dashboard dedicated to the healthcare market - built specifically for decision-makers, strategists, and industry leaders. The dashboard features comprehensive statistical data, segment-wise market breakdowns, regional performance shares, detailed company profiles, annual updates, and much more. From market sizing to competitive intelligence, this powerful tool is one-stop solution to your gateway.

Access the Dashboard:

About Us

Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics, with a strong emphasis on life science research

You can place an order or ask any questions, please feel free to contact us at ...

Europe Region: +44 778 256 0738

North America Region: +1 8044 4193 44

APAC Region: +91 9356 9282 04

Web:

Our Trusted Data Partners

Precedence Research | Statifacts | Towards Packaging | Towards Automotive | Towards Food and Beverages | Towards Chemical and Materials | Towards Consumer Goods | Towards Dental | Towards EV Solutions | Nova One Advisor | Healthcare Webwire | Packaging Webwire | Automotive Webwire | Nutraceuticals Func Foods | Onco Quant | Sustainability Quant | Specialty Chemicals Analytics

Find us on social platforms: LinkedIn | Twitter | Instagram | Medium | Pinterest